Pyridazine based inhibitors of p38 MAPK

Bioorg Med Chem Lett. 2002 Feb 25;12(4):689-92. doi: 10.1016/s0960-894x(01)00834-4.

Abstract

Trisubstituted pyridazines were synthesized and evaluated as in vitro inhibitors of p38MAPK. The most active isomers were those possessing an aryl group alpha and a heteroaryl group beta relative to the nitrogen atom in the 2-position of the central pyridazine. Additionally, substitution in the 6-position of the central pyridazine with a variety of dialkylamino substituents afforded a set of inhibitors having good (p38 IC50 1-20 nM) in vitro activity.

MeSH terms

  • Anti-Inflammatory Agents / chemical synthesis
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Inhibitory Concentration 50
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Pyridazines / chemical synthesis
  • Pyridazines / pharmacology*
  • Structure-Activity Relationship
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • Pyridazines
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases